Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients
Annamaria Cattaneo, Clarissa Ferrari, Rudolf Uher, et al.
The International Journal of Neuropsychopharmacology (2016) Vol. 19, Iss. 10, pp. pyw045-pyw045
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis
Cristiano A. Köhler, Thiago Holanda Freitas, Brendon Stubbs, et al.
Molecular Neurobiology (2017)
Closed Access | Times Cited: 413
What does plasma CRP tell us about peripheral and central inflammation in depression?
Jennifer C. Felger, Ebrahim Haroon, Trusharth Patel, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 6, pp. 1301-1311
Open Access | Times Cited: 356
Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation
Carmine M. Pariante
European Neuropsychopharmacology (2017) Vol. 27, Iss. 6, pp. 554-559
Open Access | Times Cited: 333
Treatment-resistant depression and peripheral C-reactive protein
Samuel R. Chamberlain, Jonathan Cavanagh, Peter de Boer, et al.
The British Journal of Psychiatry (2018) Vol. 214, Iss. 1, pp. 11-19
Open Access | Times Cited: 329
Biomarkers for depression: recent insights, current challenges and future prospects
Rebecca Strawbridge, Allan H. Young, Anthony J. Cleare
Neuropsychiatric Disease and Treatment (2017) Vol. Volume 13, pp. 1245-1262
Open Access | Times Cited: 323
<p>Management of Treatment-Resistant Depression: Challenges and Strategies</p>
Daphne Voineskos, Zafiris J. Daskalakis, Daniel M. Blumberger
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 221-234
Open Access | Times Cited: 313
Brain microglia in psychiatric disorders
Valeria Mondelli, Anthony C. Vernon, Federico Turkheimer, et al.
The Lancet Psychiatry (2017) Vol. 4, Iss. 7, pp. 563-572
Open Access | Times Cited: 247
Is there an association between diet and depression in children and adolescents? A systematic review
Sundus Khalid, Claire Williams, Shirley Reynolds
British Journal Of Nutrition (2016) Vol. 116, Iss. 12, pp. 2097-2108
Open Access | Times Cited: 236
Genetic Contributions of Inflammation to Depression
Jacob Barnes, Valeria Mondelli, Carmine M. Pariante
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 81-98
Open Access | Times Cited: 210
Immune targets for therapeutic development in depression: towards precision medicine
Wayne C. Drevets, Gayle Wittenberg, Edward T. Bullmore, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 3, pp. 224-244
Open Access | Times Cited: 210
Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians
Kamilla Woznica Miskowiak, KE Burdick, Anabel Martínez‐Arán, et al.
Bipolar Disorders (2018) Vol. 20, Iss. 3, pp. 184-194
Open Access | Times Cited: 167
Low-Grade Inflammation as a Predictor of Antidepressant and Anti-Inflammatory Therapy Response in MDD Patients: A Systematic Review of the Literature in Combination With an Analysis of Experimental Data Collected in the EU-MOODINFLAME Consortium
Gara Arteaga-Henríquez, Maria S. Simon, Bianka Burger, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 167
Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank
Maria C. Pitharouli, Saskia P. Hagenaars, Kylie P. Glanville, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 6, pp. 522-529
Closed Access | Times Cited: 155
Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin
Myles Corrigan, Aoife M. O’Rourke, Barry Moran, et al.
Neuronal Signaling (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 49
Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges
Michael J. Lucido, Boadie W. Dunlop
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 161-161
Open Access | Times Cited: 3
The Anti-inflammatory Potential of Tricyclic Antidepressants (TCAs): A Novel Therapeutic Approach to Atherosclerosis Pathophysiology
Majid Eslami, Marzieh Monemi, Masoud Nazari, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 197-197
Open Access | Times Cited: 2
Inflammatory profiles of severe treatment-resistant depression
Rebecca Strawbridge, John Hodsoll, Timothy R. Powell, et al.
Journal of Affective Disorders (2018) Vol. 246, pp. 42-51
Open Access | Times Cited: 103
Biomarkers of Post-COVID Depression
Piotr Lorkiewicz, Napoleon Waszkiewicz
Journal of Clinical Medicine (2021) Vol. 10, Iss. 18, pp. 4142-4142
Open Access | Times Cited: 92
Inflammation and decreased functional connectivity in a widely-distributed network in depression: Centralized effects in the ventral medial prefrontal cortex
Lijun Yin, Xiaodan Xu, Gang Chen, et al.
Brain Behavior and Immunity (2019) Vol. 80, pp. 657-666
Open Access | Times Cited: 91
Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study
Annamaria Cattaneo, Clarissa Ferrari, Lorinda Turner, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 91
Cortisol, inflammatory biomarkers and neurotrophins in children and adolescents with attention deficit hyperactivity disorder (ADHD) in Taiwan
Jane Pei‐Chen Chang, Valeria Mondelli, Senthil Kumaran Satyanarayanan, et al.
Brain Behavior and Immunity (2020) Vol. 88, pp. 105-113
Closed Access | Times Cited: 78
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 1084-1117
Open Access | Times Cited: 73
Pro- and Anti-Inflammatory Properties of Interleukin in Vitro: Relevance for Major Depression and Human Hippocampal Neurogenesis
Alessandra Borsini, Maria Grazia Di Benedetto, Juliette Giacobbe, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 23, Iss. 11, pp. 738-750
Open Access | Times Cited: 72
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
Emma I Kopra, Valeria Mondelli, Carmine M. Pariante, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 8, pp. 934-945
Open Access | Times Cited: 59
Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study
Mandakh Bekhbat, Zhihao Li, Namrataa D. Mehta, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 10, pp. 4113-4121
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top